Findings from several studies have consistently found that genetic polymorphisms in IGF1 and/or IGFBP3 are associated with the risk or prognosis of various cancers, including colorectal cancer14, lung cancer15, prostate cancer16, and breast cancer17. Here, IGFBP3 is linked to cancer.